Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01286350 · ClinicalTrials.gov registry record · NA
FL3X Study: An Adaptive Intervention to Improve Outcomes for Youth With Type 1 Diabetes (FL3X)
A NA study, sponsored by University of North Carolina, Chapel Hill.
- Completed
- Registry status
- NA
- Development phase
- 258
- Enrollment target
NCT01286350 is a NA study that has completed, run by University of North Carolina, Chapel Hill. The registered enrollment target is 258 participants.
The verdict
NCT01286350, a NA study, has completed, sponsored by University of North Carolina, Chapel Hill.
- COMPLETED
- Registry status
- NA
- Development phase
- 258 participants
- Enrollment target
Study Summary
The purpose of this study is to see if a behavioral intervention for adolescents with type 1 diabetes will improve adherence to T1D self-management activities and improve diabetes outcomes. We expect the intervention to improve diabetes outcomes when compared to usual care.
Interventions
- BEHAVIORAL FL3X: Flexible Lifestyle Empowering Change
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 258 participants |
| Start Date | 2014-05 |
| Est. Completion | 2018-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01286350
The ClinicalTrials.gov registry entry for NCT01286350 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 258 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of North Carolina, Chapel Hill, which has 1,109 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which FL3X: Flexible Lifestyle Empowering Change is the first listed.
NCT01286350 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01286350 about?
NCT01286350 is a clinical study titled "FL3X Study: An Adaptive Intervention to Improve Outcomes for Youth With Type 1 Diabetes (FL3X)". The purpose of this study is to see if a behavioral intervention for adolescents with type 1 diabetes will improve adherence to T1D self-management activities and improve diabetes outcomes. We expect the intervention to improve diabetes outcomes when compared to usual care.
What is the current status of trial NCT01286350?
This trial is currently completed. It is a NA study. The enrollment target is 258 participants. The study started on 2014-05. Estimated completion is 2018-01.
What interventions are being tested in trial NCT01286350?
The interventions under investigation include: FL3X: Flexible Lifestyle Empowering Change (BEHAVIORAL).
Who is sponsoring clinical trial NCT01286350?
This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.